Drugs / BAT8009
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05405621 | Aug 2022 → Dec 2023 | — | Bio-Thera Solutions | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAT8009 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05405621 ↗ |
| Route | Intravenous | “90-minute (± 5min) IV infusion” NCT05405621 ↗ |